テニ・シド
- 同
- VM-26
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2015/08/24 12:54:14」(JST)
[Wiki en表示]
|
This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (May 2015) |
Teniposide
|
Systematic (IUPAC) name |
(5R,5aR,8aR,9S)-5,8,8a,9-Tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-9-({4,6-O-[(R)-2-thienylmethylene]-β-D-glucopyranosyl}oxy)furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one
|
Clinical data |
AHFS/Drugs.com |
monograph |
MedlinePlus |
a692045 |
Pregnancy
category |
- AU: D
- US: D (Evidence of risk)
|
Legal status |
|
Routes of
administration |
Intravenous |
Pharmacokinetic data |
Bioavailability |
n/a |
Protein binding |
>99% |
Metabolism |
Hepatic (CYP2C19-mediated) |
Biological half-life |
5 hours |
Excretion |
Renal and fecal |
Identifiers |
CAS Registry Number |
29767-20-2 Y |
ATC code |
L01CB02 |
PubChem |
CID: 34698 |
IUPHAR/BPS |
6843 |
DrugBank |
DB00444 N |
ChemSpider |
31930 N |
UNII |
957E6438QA N |
KEGG |
D02698 Y |
ChEBI |
CHEBI:75988 N |
ChEMBL |
CHEMBL1200536 N |
Chemical data |
Formula |
C32H32O13S |
Molecular mass |
656.655 g/mol |
N (what is this?) (verify) |
Teniposide (Vumon, VM-26) is a chemotherapeutic medication[1] mainly used in the treatment of childhood acute lymphocytic leukemia (ALL). It is in a class of drugs known as podophyllotoxin derivatives and slows the growth of cancer cells in the body.
Contents
- 1 Mechanism of action
- 2 Administration
- 3 Side-effects
- 4 References
Mechanism of action
Teniposide causes dose-dependent single- and double-stranded breaks in DNA and DNA-protein cross-links. The mechanism of action appears to be related to the inhibition of type II topoisomerase activity since teniposide does not intercalate into DNA or bind strongly to DNA. The cytotoxic effects of teniposide are related to the relative number of double-stranded DNA breaks produced in cells, which are a reflection of the stabilization of a topoisomerase II-DNA intermediate.
Administration
The medication is injected though a vein and burns if it leaks under the skin. It is sometimes used in combination with other anticancer drugs.
Side-effects
Teniposide, when used with other chemotherapeutic agents for the treatment of ALL, results in severe myelosuppression. Other common side effects include gastrointestinal toxicity, hypersensitivity reactions, and alopecia.
References
- ^ Cragg, Gordon M.; Newman, David J. (2005). "Plants as a source of anti-cancer agents". Journal of Ethnopharmacology 100 (1–2): 72–9. doi:10.1016/j.jep.2005.05.011. PMID 16009521.
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Separating chemotherapy-related developmental neurotoxicity from cytotoxicity in monolayer and neurosphere cultures of human fetal brain cells.
- Ivanov DP1, Al-Rubai AJ2, Grabowska AM3, Pratten MK4.
- Toxicology in vitro : an international journal published in association with BIBRA.Toxicol In Vitro.2016 Dec;37:88-96. doi: 10.1016/j.tiv.2016.09.007. Epub 2016 Sep 10.
- Chemotherapy-induced neurotoxicity can reduce the quality of life of patients by affecting their intelligence, senses and mobility. Ten percent of safety-related late-stage clinical failures are due to neurological side effects. Animal models are poor in predicting human neurotoxicity due to intersp
- PMID 27622579
- Preparation and evaluation of teniposide-loaded polymeric micelles for breast cancer therapy.
- Chu B1, Shi S2, Li X2, Hu L3, Shi L3, Zhang H3, Xu Q3, Ye L3, Lin G3, Zhang N3, Zhang X4.
- International journal of pharmaceutics.Int J Pharm.2016 Nov 20;513(1-2):118-129. doi: 10.1016/j.ijpharm.2016.09.005. Epub 2016 Sep 3.
- Self-assembled polymeric micelles have been widely applied in anticancer drug delivery systems. Teniposide is a broad spectrum and effective anticancer drug, but its poor water-solubility and adverse effects of commercial formulation (VM-26) restrict its clinical application. In this work, teniposid
- PMID 27596115
- Biotechnological interventions for harnessing podophyllotoxin from plant and fungal species: current status, challenges, and opportunities for its commercialization.
- Kumari A1,2, Singh D1, Kumar S1,2.
- Critical reviews in biotechnology.Crit Rev Biotechnol.2016 Sep 20:1-15. [Epub ahead of print]
- Podophyllotoxin is an aryltetralin lignan synthesized in several plant species, which is used in chemotherapies for cancers and tumor treatment. More potent semisynthetic derivatives of podophyllotoxin such as etoposide and teniposide are being developed and evaluated for their efficacy. To meet the
- PMID 27644897
Japanese Journal
- Improved high-performance liquid chromatographic analysis of teniposide in human plasma
- Journal of chromatography. B, Biomedical sciences and applications 709(2), 315-319, 1998-05-29
- NAID 10024528775
- Prevention of brefeldin A-induced resistance to teniposide by the proteasome inhibitor MG-132 : involvement of NF-κB activation in drug resistance
- Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer
Related Links
- Read more about the pharmacogenomics of teniposide on PharmGKB. ... Disclaimer: The PharmGKB's clinical annotations reflect expert consensus based on clinical evidence and peer-reviewed literature available at the time they ...
- Teniposide is a cancer medication that interferes with the growth and spread of cancer cells in the body. Teniposide is used to treat acute lymphoblastic leukemia (a type of blood cancer) in children. Teniposide is usually given after ...
Related Pictures
★リンクテーブル★
[★]
- 英
- irinotecan IRT, CPT-11
- 同
- 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin]
- 化
- 塩酸イリノテカン irinotecan hydrochloride、イリノテカン塩酸塩
- 商
- カンプト、トポテシン
- 関
- 抗悪性腫瘍薬
- 抗腫瘍性植物成分製剤
概念
作用機序
- トポイソメラーゼの機能を阻害してDNA合成を阻害する
block topoisomerase function
- 同じグループの薬剤
[★]
- 日
- 関
- 同
- tenoposide
- 関
- teniposide
- 関
- Teniposide
- 関
- Teniposide
[★]
- 同
- tenoposide
- 関
- teniposide